title: NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46.
abstract: Interleukin-2 (IL-2)-activated polyclonal or clonal NK cells lysed autologous antigen presenting cells (APC) through the engagement of the natural cytotoxicity receptors (NCR) NKp30 and NKp46. NK cell-mediated cytolysis of APC correlated with the surface density of these NCR. Indeed, NK cell clones bearing low amounts of NKp30 and NKp46 did not lyse autologous APC, whereas NK cell clones with bright expression of these NCR efficiently killed autologous APC. Upon masking of NKp30 or NKp46 by specific monoclonal antibodies a strong reduction (by 50%) of APC lysis could be detected and the complete inhibition was achieved by the simultaneous masking of these NCR. Interestingly, NK cell-mediated APC lysis was impaired by the phosphatidylinositol 3-kinase (PI-3 K) inhibitors LY294002 or wortmannin. Similarly, these drugs strongly reduced NK cell activation triggered by NKp30 or NKp46 in a re-directed killing assay as well as the activation of Akt/PKB, substrate of PI-3 K, induced by the engagement of these receptors. Altogether, these findings strongly suggest that NCR are responsible for the killing of autologous APC through the activation of PI-3 K.
authors.affiliation: Laboratory of Immunology, National Cancer Research Institute, Genova, Italy.
authors.forename: G M
authors.initials: GM
authors.lastname: Spaggiari
authors.forename: R
authors.initials: R
authors.lastname: Carosio
authors.forename: D
authors.initials: D
authors.lastname: Pende
authors.forename: S
authors.initials: S
authors.lastname: Marcenaro
authors.forename: P
authors.initials: P
authors.lastname: Rivera
authors.forename: M R
authors.initials: MR
authors.lastname: Zocchi
authors.forename: L
authors.initials: L
authors.lastname: Moretta
authors.forename: A
authors.initials: A
authors.lastname: Poggi
mesh_terms: D000938:Antigen-Presenting Cells / Q000276:immunology*; D000954:Antigens, Surface / Q000096:biosynthesis; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D006801:Humans; D007694:Killer Cells, Natural / Q000166:cytology / Q000276:immunology*; D055627:Natural Cytotoxicity Triggering Receptor 1; D055629:Natural Cytotoxicity Triggering Receptor 2; D055628:Natural Cytotoxicity Triggering Receptor 3; D019869:Phosphatidylinositol 3-Kinases / Q000276:immunology*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011971:Receptors, Immunologic / Q000096:biosynthesis / Q000276:immunology*
chemical_list: D000954:Antigens, Surface; D015395:Histocompatibility Antigens Class I; D055627:Natural Cytotoxicity Triggering Receptor 1; D055629:Natural Cytotoxicity Triggering Receptor 2; D055628:Natural Cytotoxicity Triggering Receptor 3; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011971:Receptors, Immunologic; C112260:NCR1 protein, human; C112837:NCR2 protein, human; C431710:NCR3 protein, human